North America Companion Diagnostics Market Size & Outlook

Name: North America Companion Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The companion diagnostics market in North America is expected to reach a projected revenue of US$ 5,996.7 million by 2030. A compound annual growth rate of 9.1% is expected of North America companion diagnostics market from 2025 to 2030.

Clinical Diagnostics
- In Vitro Diagnostics
  - Companion Diagnostics Market Outlook

North America companion diagnostics product and services outlook (Revenue, USD million, 2021-2033)
- Assays, Kits, and Reagents
- Instruments and Systems
- Software and Services
North America companion diagnostics indication outlook (Revenue, USD million, 2021-2033)
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Other Indications
North America companion diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Polymerase Chain Reaction (PCR)
- Next-generation Sequencing (NGS)
- In-situ Hybridisation (ISH)
- "Immunohistochemistry (IHC) "
- Magnetic Resonance Imaging (MRI)
- Other Technology
North America companion diagnostics type outlook (Revenue, USD million, 2021-2033)
- Tissue Samples
- Blood Samples
- Other Sample Types
North America companion diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Academic and Research Centers
- Hospitals and Physician Laboratories
- CROs
- Reference Labaoratories
- Pharmaceutical and Biotechnology Companies
- Other End Use

North America Companion Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!